Cell-free systems for nanobiomaterials assembly.

Area of Science:

• Nanobiotechnology and Synthetic Biology
• Biomaterials Engineering
• Molecular Manufacturing

Background:

• Nanobiomaterials integrate biological molecules with synthetic components for programmable functionality.
• Current in vivo nanomanufacturing faces challenges like cytotoxicity and limited control.
• Cell-free systems (CFS) offer a solution by using cellular lysates without viability constraints.

Purpose of the Study:

• To explore the potential of cell-free systems for advanced nanobiomanufacturing.
• To demonstrate the advantages of CFS over traditional in vivo methods.
• To highlight the programmability and scalability of CFS for nano-bio hybrid systems.

Main Methods:

• Utilizing crude prokaryotic or eukaryotic cell lysates retaining transcription-translation machinery.
• Employing platforms like the reconstituted PURE system for template-directed synthesis.
• Incorporating noncanonical elements such as synthetic polymers and unnatural amino acids.

Main Results:

• Achieved high yields of cytotoxic peptides and accelerated DNA origami fabrication.
• Demonstrated assembly of hybrid enzyme-polymer conjugates with retained activity.
• Showcased diverse CFS sources (bacterial, yeast, mammalian) for specific modifications.

Conclusions:

• Cell-free biofabrication provides a controllable, high-fidelity platform for nanobiomanufacturing.
• Decoupling molecular construction from living systems enables rational engineering of nano-bio hybrids.
• CFS coupled with AI and automation represent a new paradigm for scalable nanobiomanufacturing in medicine and industry.